2002
DOI: 10.1159/000064710
|View full text |Cite
|
Sign up to set email alerts
|

Resection for pancreatic cancer in the new millennium

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
29
0
2

Year Published

2003
2003
2010
2010

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 43 publications
(33 citation statements)
references
References 76 publications
(65 reference statements)
2
29
0
2
Order By: Relevance
“…In clinical routine the only limiting factor is the availability of EUS. However, treatment of patients with pancreatic disease is mostly restricted to specialized centers which offer EUS routinely to their patients, therefore EUS-FNA can be offered to the majority of patients [14][15][16].…”
Section: Confirmation Of Diagnosismentioning
confidence: 99%
“…In clinical routine the only limiting factor is the availability of EUS. However, treatment of patients with pancreatic disease is mostly restricted to specialized centers which offer EUS routinely to their patients, therefore EUS-FNA can be offered to the majority of patients [14][15][16].…”
Section: Confirmation Of Diagnosismentioning
confidence: 99%
“…Only 20% of patients suffering from pancreatic cancer are amenable to surgical resection at diagnosis [1,2,3,4]. Among unresectable neoplasms it is important to distinguish between ductal adenocarcinoma and other tumors that have different management modalities and prognoses, such as endocrine carcinoma or metastases of non-pancreatic primary tumors to the pancreas.…”
Section: Introductionmentioning
confidence: 99%
“…Pancreatic resection for suspected neoplasia requires extensive patient preparation, commitment of appropriate theatre staff and time, a major abdominal incision, intensive care support, and a long recovery including an inpatient stay not usually less than 2 weeks [1, 2]. Whilst pancreatic resection for carcinoma is associated with a 5-year survival of 10–20% and perhaps more with adjuvant treatment [3, 4], resection is neither feasible nor possible in the majority, for whom median survival is usually less than 6 months [5].…”
Section: Introductionmentioning
confidence: 99%